Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Recruiting 4Completed 4Active not recruiting 2

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Conditions

Breast Neoplasms 1780Neoplasms 1500Carcinoma, Non-Small-Cell Lung 1045Prostatic Neoplasms 958Colorectal Neoplasms 882Lung Neoplasms 803Pancreatic Neoplasms 573Carcinoma, Hepatocellular 543Leukemia, Myeloid, Acute 541Stomach Neoplasms 513Ovarian Neoplasms 508Neoplasm Metastasis 499Multiple Myeloma 494Recurrence 412Melanoma 387Squamous Cell Carcinoma of Head and Neck 370Brain Neoplasms 362Uterine Cervical Neoplasms 361Head and Neck Neoplasms 356Esophageal Neoplasms 312Precursor Cell Lymphoblastic Leukemia-Lymphoma 310Lymphoma 306Endometrial Neoplasms 305Triple Negative Breast Neoplasms 299Glioblastoma 299Rectal Neoplasms 282Sarcoma 266Urinary Bladder Neoplasms 264Hematologic Neoplasms 264Colonic Neoplasms 255

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Solid Malignancies × Clear all
NCT06725381 2026-05-08

A Phase 1 Study of SKB571 in Subjects With Advanced Solid Tumors

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Phase 1 Recruiting
138 enrolled

Solid Malignancies

NCT07505771 2026-04-06

A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer

Immunome, Inc.

Phase EARLY_PHASE1 Recruiting
105 enrolled

Solid Malignancies

NCT06600789 2025-11-03

A Modular Phase 1/2 Study With CT7439 in Participants With Solid Malignancies

Carrick Therapeutics Limited

Phase 1/2 Recruiting
50 enrolled

Solid Malignancies

NCT06933069 2025-09-11

Safety and Tolerability of CMAB017 In Patients With Advanced Solid Tumors

Taizhou Mabtech Pharmaceutical Co.,Ltd

Phase 1 Recruiting
55 enrolled

Solid Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡